The IMPROVE PD consortium connects leading academic and industrial researchers in this field internationally, who will cooperate in the shared goal of understanding the mechanisms of inflammation-driven cardiovascular disease in PD patients, developing individualized approaches to identify those at risk, and testing new therapies in them.
CONSORTIUM MEMBERS
COORDINATOR
Agencia Estatal Consejo Superior de Investigaciones Científicas (ES)
|
BENEFICIARIES |
PARTNER ORGANISATIONS |
|
Cardiff University (UK) |
Dutch Kidney Foundation (NL) |
|
Baxter Healthcare (AT) |
The European Peritoneal Dialysis Association (UK) |
|
INSERM Nancy Clinical Investigation Centre (FR) |
Fresenius Medical Care (DE) |
|
University of Keele (UK) |
Kidney Research UK (UK) |
|
Medical University of Vienna (AT) |
Delta 4 (AT) |
|
Université Catholique de Louvain (BE) |
Servicio Madrileño de Salud- Instituto de Investigación del Hospital Universitario La Paz (ES) |
|
Universitaets-Klinikum Heidelberg (DE) |
University of Ghent (BE) |
|
Amsterdam UMC (NL) |
Renal Registry UK (UK) |
|
Zytoprotec GmbH (AT) |
Australia/New Zealand Renal Registry (AU) |
|
Universidad Autónoma de Madrid (ES) |
Poznan University of Medical Science (PL) |
|
|
Institut de Recerca Biomèdica de Lleida (ES) |